Literature DB >> 11427038

Do human platelets express COX-2?

R Reiter1, U Resch, H Sinzinger.   

Abstract

The rate-limiting enzyme in prostaglandin (PG)- and thromboxane (TX)-synthesis is known as cyclooxygenase (COX). The COX-enzyme family consists of the classical COX-1 and the inducible COX-2-enzyme. To investigate whether platelets contain COX-2, we measured thiobarbituric acid reactive substances (TBARS) after either blocking COX-1 or COX-2 or adding compounds known to affect COX-expression. To stimulate platelets' different reagents such as collagen, thrombin and arachidonic acid (AA) were used. The inhibitors used in this study were acetylsalicylic acid (ASA), indomethacin and NS-398. Using the western-blot technique, we failed to detect COX-2 in platelets while COX-1 was detectable. We were not able to discover COX-2 in platelets using the methods we applied. As the amount of COX-2 in platelets might be below the detection limit of the methods used, the biological relevance COX-2 in platelets, if even existing at low amounts, remains to be established. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427038     DOI: 10.1054/plef.2001.0276

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  6 in total

1.  Platelets participate in synovitis via Cox-1-dependent synthesis of prostacyclin independently of microparticle generation.

Authors:  Eric Boilard; Katherine Larabee; Ruslan Shnayder; Kathleen Jacobs; Richard W Farndale; Jerry Ware; David M Lee
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

2.  Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis.

Authors:  Takehiro Ochi; Toshio Goto
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

3.  Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.

Authors:  Giovanni Sitia; Roberto Aiolfi; Pietro Di Lucia; Marta Mainetti; Amleto Fiocchi; Francesca Mingozzi; Antonio Esposito; Zaverio M Ruggeri; Francis V Chisari; Matteo Iannacone; Luca G Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

4.  Lipopolysaccharide is a direct agonist for platelet RNA splicing.

Authors:  Pavel N Shashkin; G Thomas Brown; Arundhati Ghosh; Gopal K Marathe; Thomas M McIntyre
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

5.  Piperine inhibits the activities of platelet cytosolic phospholipase A2 and thromboxane A2 synthase without affecting cyclooxygenase-1 activity: different mechanisms of action are involved in the inhibition of platelet aggregation and macrophage inflammatory response.

Authors:  Dong Ju Son; Satoshi Akiba; Jin Tae Hong; Yeo Pyo Yun; Seock Yeon Hwang; Young Hyun Park; Sung Eun Lee
Journal:  Nutrients       Date:  2014-08-22       Impact factor: 5.717

6.  Bitis arietans Snake Venom Induces an Inflammatory Response Which Is Partially Dependent on Lipid Mediators.

Authors:  Angela Alice Amadeu Megale; Fernanda Calheta Portaro; Wilmar Dias Da Silva
Journal:  Toxins (Basel)       Date:  2020-09-14       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.